The Lancet Healthy Longevity (LHL)

The Lancet Healthy Longevity is a gold open-access, multi-disciplinary journal that publishes clinically-focussed longevity and healthy ageing research and review. The broad research remit aims to encompass early-stage clinical research into the mechanisms of ageing at any stage of life through to epidemiological and societal research on changing populations, including clinical trials in all disciplines focussed, but not exclusively, on older people, gerontological science, and age-specific clinical guidelines. We will also publish clinical and policy reviews which aim to shape and contextualise the debate on this fast-growing discipline. The Lancet Healthy Longevity will continue in the Lancet family tradition of being a strong advocate for the rights of all people to healthy, fulfilling lives, irrespective of age, and prioritises reports of original research that are likely to change clinical practice or thinking.

The Lancet Healthy Longevity (LHL) is :-

• International, Peer-Reviewed, Open Access, Refereed, Geriatrics and gerontology, Healthy ageing and longevity research, Public health and epidemiology, Clinical medicine related to ageing, Health systems and ageing populations, cognitive decline, frailty, multimorbidity, preventive healthcare strategies for older adults, Interdisciplinary studies that integrate epidemiology, clinical trials, health policy are strongly encouraged , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2666-7568, Established: 2020,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE